1. Serogroup B Meningococcal Disease

2. Program Overview

3. N. meningitidis and IMD

4. Meningococcal Serogroups: Global Distribution

5. Incidence of MenB Disease

6. Greater Heterogeneity Among Serogroup B Isolates

7. MenB Outbreaks: Frequent and Prolonged

8. Key Messages

9. MenB Infection and Prevention in the Czech Republic

10. Serogroup Distribution and Incidence of IMD

11. Clonal Complexes of N. meningitidis From IMD

12. Age-Specific Incidence of IMD: Surveillance Data

13. Coverage of Czech N meningitidis Isolates in 4CMenB Vaccine

14. Conclusion

15. MenB Infection and Prevention in Italy

16. Incidence of IMD,

17. IMD by Serogroup,

18. Incidence of IMD by Age Group in Italy

19. MenB Vaccination: National Immunization Plan Since 2017

20. Conclusion

21. MenB Infection and Prevention in the United Kingdom

22. UK National Immunization Plan for MenB

23. Uptake of 4CMenB

24. Rapid Decline in MenB Disease Since Implementation

25. Other Progress With MenB Since Implementation

26. Key Messages

27. Closing Remarks

28. Key Messages

29. Abbreviations

30. Abbreviations (cont)